Verici Dx (LSE:VRCI) will offer up to £200,000 of new shares to UK retail investors via Winterflood's WRAP platform, following a placing that raised approximately £2.5m.
The AIM‑listed precision diagnostics developer, focused on transplant tests, is making up to 57.14m WRAP Retail Offer Shares available at 0.35p each, matching the placing price and totalling up to £200,000.
The placing issued 700m new shares at 0.35p, raising approximately £2.5m and representing a 17.6% discount to Verici Dx's closing mid-price on 4 June, and the company says WRAP proceeds will be used the same way as the placing proceeds.
The issue of WRAP Retail Offer Shares is conditional on shareholder approval at a general meeting expected on 22 June and on admission to trading on AIM, which the company expects to take effect at or around 08:00 on 23 June.
The WRAP Retail Offer is expected to close at 14:00 on 11 June (intermediaries may set earlier deadlines) and the result is expected to be announced on or around 12 June.
There is a £100 minimum subscription and the company notes it received HMRC advance assurance on 11 July 2025 that certain shares would be EIS‑eligible but has not applied for an updated assurance, so EIS relief cannot be guaranteed.
Investors are reminded that an investment in the company's shares carries risk and that the next timetable milestone is the shareholder meeting on 22 June.
